Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Among the many things columnist Candace Semien had to learn while living with lupus were the types and function of various ...

A recent study of three groups of patients with systemic lupus erythematosus (SLE) has, for the first time, identified a link between iron deficiency and fatigue.

Seattle Children's will start a clinical trial testing CAR T-cell therapy in children with lupus this summer after getting FDA clearance.

A recent beach adventure prompts columnist Candace Semien to reflect on the value of doing something for the first time.

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

Omalizumab is well-tolerated and reduces disease activity in patients with systemic lupus erythematosus, a Phase 1b trial shows.

Sweet potatoes often appear at Thanksgiving and other holidays, but it’s time for them to be in the spotlight. Eating them can benefit your health.

The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).

A Phase 1 trial found an infusion of mesenchymal stem cells lowered auto-reactive immune cell levelss in lupus patients; a Phase 2 study is starting in US.

Read about early research suggesting irinotecan, a topoisomerase I blocker, shows strong potential as a lupus treatment and arguing for studies in patients.

A lab study suggests that overproduction of a molecule called IFN-I, which promotes inflammation, may be due to mitochondrial injury, like oxidative stress.